In the News: Inhaled Levofloxacin & QIDP Designation


Raptor Pharmaceutical’s MP-376 (Inhaled Levofloxacin) granted QIDP Status by the FDA on March 16, 2016. What is Qualified Infectious Disease […]

Read More

We Lobby


A Brief History of Our Lobbying Efforts in 2015   In April, 2015, we sent this letter to the FDA […]

Read More